DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
O••••• C••• H••••• I••
H•••••care & Pharmaceuticalsgroup grade Aoff every schedule since Dec 31, 2025sponsor unattributed
Nothing material in the last 200 days. No dated change on record yet.
Mark path, consensus per quarter end
100¢ · 101¢ · 100¢ · 100¢ · 101¢Q1 2024 to Q4 2025
Principal held
at least $206,000
sum of BDC pieces, a lower bound
Fair value
$208,000
101c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Sep 16, 2032
no dated debt inside 24 months
On the tape since
Jun 30, 2023
latest Dec 31, 2025
Events
4
dated, non-routine
Lender marks
each lender's own fair value over cost at Dec 31, 2025, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| S••••• C•••• C•••••• C••• | $206K | 101¢ | new this quarter |
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| S••••• C•••• C•••••• C••• | term loan first lien F•••• L••• - T••• L••• | $206,000 | $208,000 101c | S+175 bp |
Capital structure as the BDCs see it
latest quarter end Dec 31, 2025
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Dec 31, 2025 | at least $206,000 | 101c | S+175 bp | Sep 16, 2032 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1 | $206,000 | $208,000 | 101c | 0 |
| Dec 31, 2024 | 1 | $4.8M | $4.8M | 100c | 0 |
| Sep 30, 2024 | 1 | $5.8M | $5.9M | 100c | 0 |
| Jun 30, 2024 | 1 | $5.9M | $5.9M | 101c | 0 |
All 8 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Mar 31, 2024 | 1 | $5.9M | $5.9M | 100c | 0 |
| Dec 31, 2023 | 1 | $5.9M | $5.9M | 100c | 0 |
| Sep 30, 2023 | 1 | $5.9M | $5.9M | 100c | 0 |
| Jun 30, 2023 | 1 | $5.5M | $5.5M | 100c | 0 |
What changed
- Facility left every BDC scheduleDec 31, 2025
- Maturity extended (observed)Dec 31, 2025
- Spread changed (observed)Jun 30, 2024
- New borrower on a BDC scheduleJun 30, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- O••••• C••• H•••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- H•••••care & Pharmaceuticalsreportedas one filer wrote it